EcoDrugPlus

Matrix Metallopeptidase 12

Ensembl ID : ENSPPRG00000012183
Gene Symbol: MMP12
4 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSPPRG00000012080
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSPPRG00000022165
Gene Symbol: MMP14
4 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPPRG00000012232
Gene Symbol: MMP2
4 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSPPRG00000014613
Gene Symbol: MMP7
4 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSPPRG00000013466
Gene Symbol: MMP8
3 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPPRG00000018154
Gene Symbol: MMP9
4 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSPPRG00000024768
Gene Symbol: MTOR
4 Cross references
214 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSPPRG00000017600
Gene Symbol: MC3R
4 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSPPRG00000019070
Gene Symbol: MC4R
3 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSPPRG00000003712
Gene Symbol: MTNR1A
4 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSPPRG00000004216
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).